Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Ketamine for Prevention of Postpartum Depression in Parturients with Prenatal Depression
NCT03336541Phase 4Completed
- Sponsor
- Peking University First Hospital
- Start
- Nov 2017
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ketamine in postpartum depression (PPD), sponsored by Peking University First Hospital. Started Nov 2017; status: completed.
02
Drugs
ketamine
03
Conditions
postpartum depression (PPD)
Beyond the preview
Go deeper on NCT03336541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03336541.